Category Archives: Neuroscience

ANU plans to end neuroscience research – The Science Show – ABC News

The restructure of the College of Health and Medicine would see the end of neuroscience research at the Eccles Institute for Neuroscience at the Australian National University. 23 staff will lose their jobs on top of the 30 jobs lost in 2020. Sir John Eccles, after whom the Institute was named made pioneering discoveries on how nerves work. He was awarded the Nobel Prize, the first awarded to any researcher at ANU. John Eccles also helped set up the first undergraduate honours course at the university. David Mark and Jonathan Webb respond to the announcement.

ANU plans to end neuroscience research as it struggles to save $103 million annually - ABC News

A portrait of Sir John Eccles - Australian Nobel laureate who devoted his life to unravelling the complexities of the human brain The Science Show 16th January 2021

GuestsDavid MarkNational Sport Reporter ABC

Jonathan WebbScience Editor ABC

PresenterRobyn Williams

ProducerDavid Fisher

Read the original:
ANU plans to end neuroscience research - The Science Show - ABC News

Neuroscience research finds distinct advertising differences across audio, radio and podcasting – CMO

Radio, podcasting and music streaming are distinctively processed by consumers, leading to differences in their strengths and effectiveness as advertising channels, a new neuro research study claims.

The fresh research, which has been conducted by neuroscience specialist, Dr Shannon Bosshard, in partnership with Australian Radio Networks Neuro Lab, sought to understand how consumers brains respond different to distinct audio formats, and the impact advertising has in each of them. To do this, it analysed more than 40,000 datapoints every second across the different audio formats and mapped brain activity of people engaging with both audio content and advertising.

According to the Sound you can see research, radio showed the strongest ability to engage listeners and for extended periods of time, racking up 60 per cent more neural engagement than other audio formats. Podcasts, meanwhile, were found to provide an environment that lends itself to higher levels of memory encoding, while music streaming options showed the strongest impact in promoting positive attitudes towards brands.

In describing the research, Dr Bosshard said radio, podcasting and music streaming are fundamentally different, thereby offering advertisers with unique opportunities to promote brands. For example, the findings highlighted a variance of up to 170 per cent in terms of attitudes around advertising when content and advertising dont match in these different audio channels.

ARN positioned the research work as the first go-to-market piece of research in this space measuring attention, engagement, attitude and memory and part of an ongoing initiative to better understand audios distinct role and impact for brands.

Up until now, no commercial or academic entity has assessed the differences in these three audio products, Dr Bosshard commented. This is the first time that anyone has demonstrated, from the perspective of the brain, that radio, podcasting and music streaming are processed differently and should be treated differently, in the same manner that audio and audio-visual mediums have been.

ARN director of research and insights, Justin Stone, said initial responses from agencies to the research has been enthusiastic. The use of neuroscience to complement traditional marketing techniques will produce a much more comprehensive view of how our listeners interact with audio formats, he said.

ARN said its Neuro Lab is now working with clients on how to evaluate and optimise impact across the three areas of focus. The lab was first established late in 2020 as an in-house media research initiative to support ARNs portfolio of products, including radio stations such as KIIS, the Pure Gold network and 96FM as well as the iHeartRadio music streaming and podcast network.

The findings come just weeks after the Interactive Advertising Bureau (IAB)of Australia published its latest Advertising Audio State of the Nation Report Wave 5, which showed podcasting and streaming digital audio advertising increased in 2020. The report found 69 per cent of media agencies now reporting streaming digital audio advertising as a significant or regular part of their activity and 36 per cent report podcast advertising as a significant or regular part of their activity.

Dont miss out on the wealth of insight and content provided by CMO A/NZ and sign up to our weekly CMO Digest newsletters and information services here.

You can also follow CMO on Twitter:@CMOAustralia, take part in the CMO conversation on LinkedIn:CMO ANZ,follow our regular updatesvia CMO Australia's Linkedin company page.

Follow this link:
Neuroscience research finds distinct advertising differences across audio, radio and podcasting - CMO

MPM Capital Strengthens Team with the Addition of Neuroscience R&D Leader David S. Bredt, MD, PhD as Executive Partner – Yahoo Finance

MPM Capital (MPM), a leading biotechnology investment firm investing in early-stage therapeutics companies, today announced that David S. Bredt, MD, PhD, has joined its team of Executive Partners.

"Were delighted to have David join MPM. His drug discovery expertise will be broadly applied to the MPM portfolio with a particular emphasis on building new companies addressing disorders of the central nervous system," said Ed Hurwitz, managing director at MPM Capital. "We see tremendous advances in the understanding of neurological dysfunction particularly in the areas of protein trafficking, neuroinflammation, neuroregeneration and ion-channel modulation. We fully expect Davids technical and managerial expertise will be of tremendous value as we delve into these exciting new opportunities."

David will take a leading role in helping MPM explore a range of opportunities, including those presented by new developments in the understanding of neurological dysfunction. This will include identifying and assessing new technologies and helping advance MPMs company formation efforts in the field of neurology.

"I am thrilled to join MPM Capital and to bring leadership in both drug discovery and the field of neurology to this accomplished team," said Dr. Bredt. "These are unprecedented times both of therapeutic need and of scientific progress. MPM has an impressive record of creating transformational biotechnology companies; I look forward to innovating with the team to deliver breakthrough new health care solutions to patients."

David S. Bredt, M.D., Ph.D.

Before joining MPM, David was Site Head for Johnson & Johnsons R&D Campus in La Jolla, which focuses on Neuroscience, Immunology and Biotechnology and is the original JLABS incubator for emerging healthcare companies. He was Global Head of Neuroscience Discovery at Johnson & Johnson where he had line management responsibility for neuroscience biology, biomarkers, and external innovation activities. His discovery group delivered numerous small and large molecule clinical candidates for Alzheimers disease, major depression, schizophrenia and epilepsy.

Story continues

David joined Eli Lilly and Company as Vice President of Integrative Biology in August 2004 and became Vice President of Neuroscience Discovery and Early Development a few years later. As head of neuroscience research at Eli Lilly, Davids group was responsible for Discovery through Phase 2 programs in Neurology, Psychiatry, Migraine, and Pain indications. His group prosecuted numerous small and large molecules that entered preclinical and clinical development including galcanezumab / Emgality, which is now approved for preventative treatment of migraine.

David graduated summa cum laude in Chemistry at Princeton University. He received his M.D. and Ph.D. at Johns Hopkins University School of Medicine, where he trained with Dr. Solomon H. Snyder. After graduation, David was Professor of Physiology at the University of California, San Francisco for ten years. His research on nitric oxide, glutamate receptor signaling, and synaptic plasticity has yielded ~225 papers, which have been cited ~75,000 times in the scientific literature. He served on the Medical Advisory Committee for the Muscular Dystrophy Association, he was an Established Investigator for the American Heart Association, and he was a National Young Investigator for the National Science Foundation.

About MPM Capital

MPM Capital is a biotechnology investment firm with over two decades of experience founding and investing in companies that seek to translate scientific innovations into cures for major diseases. With its experienced and dedicated team of investment professionals, entrepreneurs, and advisors, MPM strives to power novel medical breakthroughs that transform patients' lives. For more information visit http://www.mpmcapital.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210407005554/en/

Contacts

Matt Burkemattdavidburke@gmail.com +1 603.315.0618

Read the original here:
MPM Capital Strengthens Team with the Addition of Neuroscience R&D Leader David S. Bredt, MD, PhD as Executive Partner - Yahoo Finance

Neuroscience Cafe Presents COVID-19 Update: – Where Are We With Testing, Treatment, and Vaccination? – thehomewoodstar.com

Join us each month as UAB neuroscientists and clinicians present and discuss how neuroscience research is improving life in your community.

Studies show that COVID-19 vaccines are effective at keeping you from getting COVID-19. Experts also think that getting a COVID-19 vaccine may help keep you from getting seriously ill even if you do get COVID-19. Because COVID-19 is a new disease with new vaccines, information is rapidly emerging about how vaccines can help us stop the pandemic. Drs. Jeanne Marazzo and David Kimberlin wil discuss what we knowand what we dont knowabout the Covid vaccines.

This event is free.

To join the Zoom meeting, email: cnc@uab.edu to register for your zoom link.

View post:
Neuroscience Cafe Presents COVID-19 Update: - Where Are We With Testing, Treatment, and Vaccination? - thehomewoodstar.com

Leaking calcium in neurons an early sign of Alzheimer’s pathology – Yale News

Alzheimers disease is known for its slow attack on neurons crucial to memory and cognition. But why are these particular neurons in aging brains so susceptible to the diseases ravages, while others remain resilient?

In a new study published April 8 in the journal Alzheimers & Dementia, The Journal of the Alzheimers Association, researchers at the Yale School of Medicine found that susceptible neurons in the prefrontal cortex develop a leak in calcium storage with advancing age. This disruption of calcium storage in turns leads to accumulation of phosphorylated, or modified, tau proteins which cause the neurofibrillary tangles in the brain that are a hallmark of Alzheimers.

These changes occur slowly, building over many years, and can be seen within neurons in the brains of very old monkeys, the researchers report.

Altered calcium signaling with advancing age is linked to early-stage tau pathology in the neurons that subserve higher cognition, said corresponding author Amy Arnsten, the Albert E. Kent Professor of Neuroscience and professor of psychology and member of the Kavli Institute of Neuroscience at Yale University.

These vulnerable neurons face another problem. As they age, they tend to lose a key regulator of calcium signaling, a protein called calbindin, which protects neurons from calcium overload, and is abundant in the neurons of younger individuals.

With age, these neurons face a double whammy, with an excessive calcium leak that initiates toxic actions, as well as diminished levels of the protectant, calbindin, said Arnsten.

Neurons in the prefrontal cortex require relatively high levels of calcium to perform their cognitive operations, but the calcium must be tightly regulated. However, as regulation is lost with increasing age, neurons become susceptible to tau pathology and degeneration. Essentially, neurons eat themselves from within.

Understanding these early pathological changes may provide strategies to slow or prevent disease progression, Arnsten said.

The study is a collaboration between the labs of Arnsten and Angus Nairn at Yale; Dibyadeep Datta and Shannon N. Leslie are co-first authors of the research.

See the original post here:
Leaking calcium in neurons an early sign of Alzheimer's pathology - Yale News

Neuroscience Market Development And Trends, CAPEX Cycle, Innovations, And The Dynamic Structure Forecast 2021-2027 – The Courier

The latest SMR Reports study titledNeuroscience Markethighlights important aspects of the Neuroscience market. The report is intended to help readers accurately estimate the growth rate of the world market during the forecast period (2020-2026). Our market research team has meticulously assessed the Neuroscience market dynamics, both quantitatively and qualitatively, taking into account a variety of factors including market penetration, product portfolios, user industries, results, pricing structure, and key drivers, restraints, opportunities, and challenges. affect market growth.

Neuroscience Market garnered revenue of USD 1.8 billion in the year 2020 globally and has been foreseen to yield USD 5.4 billion by the year 2026at a compound annual growth (CAGR) of 6.9% over the forecast period.

The latest market research largely segments the industry based on product types, application areas, end-use industries, key regions, and competitive environment. One of the central components of the report is a detailed explanation of the gross profit, the share of sales, the sales volume, the manufacturing costs, the individual growth rate, and the financial position of the main market participants. The scope of development of newcomers and established companies in the Neuroscience market was also highlighted in the report.

Download Exclusive Sample PDF along with few company profiles @https://www.syndicatemarketresearch.com/sample/neuroscience-market

Competitive Field:

The Neuroscience market is highly consolidated due to the presence of many companies operating in this sector. The report describes the current market position of these companies, their past performance, graphs of supply and demand, production and consumption patterns, distribution network, sales channels, and growth opportunities in the market. The main market candidates listed in the report are:

Market Segments by Major Manufacturers:Doric Lenses Inc, GE Healthcare, Siemens Healthineers, Laserglow Technologies, Mightex Systems, Prizmatix, Kendall Research Systems LLC, Noldus Information Technology, Med Associates Inc, Phoenix Technology Group, NeuroNexus

Impact Of COVID-19

The most recent report includes extensive coverage of the significant impact of the COVID-19 pandemic on the Neuroscience division. The coronavirus epidemic is having an enormous impact on the global economic landscape and thus on this special line of business. Therefore, the report offers the reader a clear concept of the current scenario of this line of business and estimates the aftermath of COVID-19.

Request a Discount on the report @https://www.syndicatemarketresearch.com/inquiry/neuroscience-market

Market Segments and Sub-segments Covered in the Report are as follow:

Neuroscience Market, By End-User

Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuro-functional analysis, Neuro-proteomic analysis, Neuro-cellular manipulation, Neuro-biochemical assays, Stereotaxic surgeries, Animal behavior

Neuroscience Market,By Application (2020-2026)

Instrumentation, Data Analysis and Services, Consumables

In this section of the report, market analysts have provided valuable insight into the geographic segmentation of the Neuroscience market. They further estimated the current and future market valuations based on the demand and supply dynamics and the pricing structure of the key regional segments. In addition, the growth prospects for each regional segment were discussed in detail in the report.

The Neuroscience Market is divided into the following regions:

North America

Latin America

Europe

Asia Pacific

The Middle East and Africa

Request customization of the report @https://www.syndicatemarketresearch.com/market-analysis/neuroscience-market.html

In continuation with this information, the sale worth is for varied sorts, applications, and regions also are enclosed. The marketplace for major regions is given. In addition, sort wise and application wise consumption figures also are given.

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia Pacific.

How Syndicate Market Reports is different than other Market Research Providers:

Go here to read the rest:
Neuroscience Market Development And Trends, CAPEX Cycle, Innovations, And The Dynamic Structure Forecast 2021-2027 - The Courier

Neuroscience Market in Healthcare Market Is Thriving Worldwide with the outstanding players KSU | The Sentinel Newspaper – KSU | The Sentinel…

The global Neuroscience Market is estimated to be valued at US$ XX billion in 2020 and is projected to reach US$ XX billion by 2027, recording a CAGR of XX %.

COVID-19 Impact on Global Neuroscience Market

We at Coherent Market Insights understand the economic impact spread to financial markets. Using our holistic market research methodology, we are focused on aiding your business sustain and grow during COVID-19 pandemics. With deep expertise across various industries-no matter how large or small and a team of highly experienced and dedicated analysts, Coherent Market Insights will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2487

National governments and international are focused on adopting collaborative efforts to encourage financial institutions to meet the financial needs of customers and members affected by the coronavirus. However, there are some sectors that have remained unscathed from the impact of the pandemic and there are some that are hit the hardest.

Global Neuroscience Market: Segments

North America United States Canada MexicoAsia Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines VietnamEurope Germany France UK Italy RussiaCentral & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa

Global Neuroscience Market: Regional Outlook

The Neuroscience held dominant position in the market and accounted for XX% share in the global Neuroscience Market in 2020. The segment is expected to reach US$ XX million in 2027.

Apply Promo Code CMIFIRST1000 And Get Instant Discount Of USD 1000

Buy This Research Study Report For Quick [emailprotected] https://www.coherentmarketinsights.com/insight/buy-now/2487

Global Neuroscience Market: Key Participants

Major players operating in the global Neuroscience Market include: Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Inc., Newport Corporation, Plexon Inc., Noldus Information Technology, Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

The report covers exhaustive analysis on:

Market Segments Market Dynamics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain

Regional analysis includes:

North America (United States, Canada, and Mexico) Asia Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, and Vietnam) Europe (Germany, France, UK, Italy, and Russia) Central & South America (Brazil) Middle East & Africa (Turkey, GCC Countries, Egypt, and South Africa)

Report Highlights:

Detailed Overview Market Dynamics Detailed Market Segmentation Historical, Current, and Projected Market Size in terms of volume and value Market Trends and Developments Competitive Landscape Strategies of Key Players Potential and Niche Segments

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Phone: US +12067016702 / UK +4402081334027Email: [emailprotected]

See the original post:
Neuroscience Market in Healthcare Market Is Thriving Worldwide with the outstanding players KSU | The Sentinel Newspaper - KSU | The Sentinel...

School of Education & Human Sciences to host 3rd session of virtual series for 2020-21 | The University of Kansas – KU Today

LAWRENCE The School of Education & Human Sciences at the University of Kansas will host the third and final virtual session of the 2020-21 Strategies Event Series on April 17 via Zoom.

The third session, Understanding Educational Neuroscience Research, will feature Michael Orosco, associate professor in the Department of Educational Psychology. The session will address advances in educational neuroscience research that has given educators insight into the workings of the mind and brain. Participants will be able to apply information about how learning and teaching affects their students brains and their capacity to grow.

We are pleased to offer another free professional development session, this time focusing on research related to neuroscience and its significance for teaching and learning, said Rick Ginsberg, dean of the School of Education & Human Sciences. Dr. Oroscos expertise in this area provides vital information for todays educators.

Oroscos virtual session will take place at 9 a.m. The session is free and open to the public, though individuals must RSVP online to receive the Zoom access information for participation. Learn more and RSVP for the session online.

About the KU School of Education & Human Sciences

Located in Lawrence, the KU School of Education & Human Sciences is a nationally ranked school, preparingeducators and human science professionals as leaders since 1909. With more than 40 academic programs offered among five departments, at two different campuses and fully online, the school serves Kansas, the nation and the world by preparing individuals to become leaders and practitioners in education and related human science fields. Stay up to date by following the School on Facebook, Twitter, and Instagram.

Link:
School of Education & Human Sciences to host 3rd session of virtual series for 2020-21 | The University of Kansas - KU Today

Global Neuroscience Market 2020 Manufacturer Landscape, Revenue and Volume Analysis and Segment Information up to 2025 The Courier – The Courier

MarketQuest.biz has published a new study on Global Neuroscience Market 2020 by Company, Regions, Type and Application, Forecast to 2025 that delivers a point-by-point analysis of the market covering valuable statistics about market size, status, and growth rate for the forecast period 2021-2026. The report includes a thorough analysis of the latest trends prevalent in this business. The report aims to deliver fundamental data to readers, strategists, senior administration, and advertisers associated with the market. The research discusses key trends that define the industry growth in terms of the regional landscape and competitive outlook. This unique and updated report precisely presents each and every aspect of the global Neuroscience industry and represents it in an easy to understandable format.

Key Insights from the Report:

The report sorts data by segment by type, application, and marketing channel. The report also states the global Neuroscience market scenario by market share, market growth (value and volume). Various important metrics are considered including SWOT analysis of players, all recent developments, upcoming launches, joint ventures, mergers, and accusations of industry-relevant players to know market size forecast and growth estimation.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/12410

Market Drivers, Limits and Opportunities:

The report also covers industry-oriented drivers, restraints, threats, and opportunities in the global Neuroscience market. The market is deeply evaluated by a current market situation such as market growth factors and constraints. The market propellants, challenges, and threats in the market are further highlighted in the report. In addition, the report offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

The major players profiled in this report include: GE Healthcare, Plexon, Mightex Bioscience, Siemens Healthineers, Tucker-Davis Technologies, Noldus Information Technology, NeuroNexus, Blackrock Microsystems, Thomas RECORDING GmbH, Phoenix Technology Group, Alpha Omega

The most important types covered in this report are: Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Other

The most widely used downstream fields of market covered in this report are: Hospitals, Diagnostic Laboratories, Research Institutes, Other

The report explores the current outlook in global and key regions including: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.marketquest.biz/report/12410/global-neuroscience-market-2020-by-company-regions-type-and-application-forecast-to-2025

The Destinations of Statistical surveying Report Are:

The fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the global Neuroscience market. The report describes the market based on the SWOT analysis of every region. The competitive scenario among major players is demonstrated based on their company profile, product introduction, value, gross margin.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketquest.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketquest.bizWeb: http://www.marketquest.biz

View original post here:
Global Neuroscience Market 2020 Manufacturer Landscape, Revenue and Volume Analysis and Segment Information up to 2025 The Courier - The Courier

Baptist Health Neurologist Addresses the Many Myths of Parkinson’s Disease – Baptist Health South Florida

What do actor Michael J. Fox, rock musician Ozzy Ozbourne and former Miami Heat star Brian Grant all have in common? Theyre just three of the 10 million people worldwide who are living with Parkinsons disease, aneurodegenerative disorder of the brain. Yet, in spite of the number of people who have Parkinsons, there are many misconceptions about the disease.

Sameea Husain Wilson, D.O., is the director of Movement Disorder Neurology at Marcus Neuroscience Institute at Boca Raton Regional Hospital, where she specializes in movement disorders such as Parkinsons disease. She spoke with Resource recently and dispelled some of the most common myths about the disease.

MYTH #1: Everyone with Parkinsons disease has tremors.

FACT: We know this is not true because 30 percent of patients with Parkinsons disease do not experience tremors, says Dr. Husain Wilson. I cant tell you how many patients Ive encountered who said, I didnt think it was Parkinsons because I dont have tremors. They delayed seeing their primary care physician or a neurologist simply because the motor symptoms they were experiencing stiffness, rigidity or balance issues didnt include tremors.

MYTH #2: Aside from medication, there isnt much you can do to treat Parkinsons disease.

FACT: Dr. Husain Wilson says she is saddened by the thought that some people believe this to be true. As patients with Parkinsons learn very quickly when they seek care at Marcus Neuroscience Institute, in addition to medications such as levodopa, there are many other therapies that can help you live with the disease and maintain a good or even great quality of life, she says.

Physical therapy helps patients with their posture, gait, arm swing and cadence, as well as learn how to use their assistive devices such as walkers or canes, according to Dr. Husain Wilson. But it requires commitment from the patient, she adds. You need to practice 30 to 60 minutes a day, every day, with your spouse or an aid who can assist you when needed.

Occupational therapy helps with daily living skills such as feeding, grooming, toileting and bathing, Dr. Husain Wilson says, and speech therapy is extremely beneficial because Parkinsons patients also have problems with voice projection and swallowing. We even address what type of diet they should be eating, given some of the limitations caused by their disease.

Walking and other exercises are extremely beneficial for people living with Parkinsons, as is aqua therapy, according to Dr. Husain Wilson. When patients are walking in water, the buoyancy of the water helps them move in a way that they cannot on land. Riding a stationary bike is also helpful, she says. Yoga and tai chi, too theyre wonderful for reducing rigidity, boosting core strength, maintaining balance and preserving mobility.

MYTH #3: All Parkinsons patients are candidates for High-Intensity Focused Ultrasound (HiFU) therapy.

FACT: There is such a large constellation of symptoms associated with Parkinsons disease, and not all patients have tremors or will develop disabling dyskinesias involuntary uncontrollable movements of one or more parts of the body, particularly the head, arms or legs commonly associated with Parkinsons, says Dr. Husain Wilson. But for patients who do have dyskinesias, she says HiFU can reduce tremors by precisely targeting ultrasound beams through the skull to the thalamus, the pea-sized structure in the brain responsible for transmitting 98 percent of sensory information to the brains cortex, including vision, taste, touch and balance.

With HiFU, we can reduce or eliminate tremors in some patients by using ultrasound beams to destroy lesions in the thalamus that are creating an abnormal circuit in the brain, Dr Husain Wilson says. Its a minimally invasive, image-guided procedure that can be performed painlessly, without anesthesia, while the patient is awake and responsive.

Patients with disabling dyskinesias may also benefit from making thermal lesions in the globus pallidus or subthalamic nucleus, she adds, while a patient with tremors or severe slowness of movement may be treated with thermal lesions in the pallidothalamic tract.

MYTH #4: HiFU is the only surgical treatment option for Parkinsons disease.

FACT: Actually, Deep Brain Stimulation (DBS) surgery has for decades been an effective therapy for many patients with Parkinsons and even today it is used more widely than HiFU, Dr. Husain Wilson says. Patients with advanced Parkinsons also benefit from the Duopa Pump, which is a surgically implanted device that delivers medicine directly to the intestine, where it is readily absorbed. This, she says, reduces the off times during the day that patients experience when taking oral medications to control their disease.

MYTH #5: Parkinsons disease is fatal.

FACT: According to Dr. Husain Wilson, for many patients first diagnosed with Parkinsons disease, the first question they ask is, How long do I have? But people dont die from the disease, she is quick to say they die with the disease.

Parkinsons disease is not fatal, she says. When fatalities do occur, its from complications associated with the disease, such as falls and choking, but not the disease itself. In most cases, Dr. Husain Wilson adds, it was because the patient wasnt following the rules of living with Parkinsons, such as keeping up with physical therapy, strengthening your core, using your assistive device wherever you go, and asking for help when needed. All of these can help prevent falls.

Because choking is also a concern with Parkinsons disease, patients need to be especially careful eating, drinking and taking medications. Eating soft or pureed foods, slowly and deliberately, can help prevent choking, Dr. Husain Wilson says. Also, because swallowing is difficult for people with Parkinsons, many patients find they can keep from aspirating fluids by adding thickeners to beverages and taking medications with applesauce or yogurt.

MYTH #6: Essential Tremor and Parkinsons disease are the same thing.

FACT: Lots of patients think theyre the same thing, because of the tremors, says Dr. Husain Wilson, but as we noted before, not all Parkinsons patients have or develop tremors. People with Parkinsons who do have tremors experience them even when their bodies are at rest, she notes, while those with Essential Tremor get them only when moving their hands and legs.

Neurologists are trained to spot the visible symptoms of Parkinsons disease, Dr. Husain says. Once a clinical diagnosis is made, further confirmation can be made, if needed, with a Dopamine Transporter Scan (DaTscan), which she says allows clinicians to see if your body is manufacturing dopamine properly.

A radioactive tracer is injected into the bloodstream where it eventually attaches to the dopamine transporter molecule on dopamine neurons in the brain, she explains. How those neurons light up under special imaging equipment can confirm whether your dopamine system is healthy or compromised. The scan alone wont make the diagnosis, she emphasizes, but it will help confirm the clinicians diagnosis.

MYTH #7: People with Parkinsons disease shouldnt get the COVID-19 vaccine.

FACT: Not true, says Dr. Husain Wilson. Your movement disorder neurologist is the only person who should be saying whether or not you should get the COVID-19 vaccine, and theyre going to tell you its safe. As a movement disorder neurologist myself, I can tell you that the only reason the vaccine might possibly be an issue was if the patient had an additional medical problem unrelated to their Parkinsons.

Tags: COVID-19 Vaccine, Marcus Neuroscience Institute, movement disorder neurology, movement disorders, Myths about Parkinson's, Parkinson's disease, Sameea Husain Wilson D.O.

View original post here:
Baptist Health Neurologist Addresses the Many Myths of Parkinson's Disease - Baptist Health South Florida